Zero-shot SpliceVarDB intronic SNVs classification (Evo 2 paper, Supplementary Data 1)
Zero-shot classification of splice-altering versus other variants in the SpliceVarDB intronic SNVs stratum, AUROC and AUPRC.
No reviewed evaluations are linked here in this release. See the sources below.
Overview
An explanatory profile has not yet been reviewed for this record.
Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.
Published results still to collect
This release has no source-checked evaluations linked to this page. It does not mean that the benchmark has no published results.
Charts will appear when compatible result tables have been checked against their sources.
Methods and evaluation design
Procedure, tasks and evaluated configurations
Recorded evaluations
Each evaluation records what was tested and under which conditions.
- CADD on SpliceVarDB intronic SNVs (Evo 2 paper)
- Evo 1 on SpliceVarDB intronic SNVs (Evo 2 paper)
- Evo 2 40B base on SpliceVarDB intronic SNVs (Evo 2 paper)
- Evo 2 40B on SpliceVarDB intronic SNVs (Evo 2 paper)
- Evo 2 7B base on SpliceVarDB intronic SNVs (Evo 2 paper)
- Evo 2 7B on SpliceVarDB intronic SNVs (Evo 2 paper)
- GPN-MSA on SpliceVarDB intronic SNVs (Evo 2 paper)
- NT on SpliceVarDB intronic SNVs (Evo 2 paper)
- Pangolin on SpliceVarDB intronic SNVs (Evo 2 paper)
- PhyloP 100 on SpliceVarDB intronic SNVs (Evo 2 paper)
- PhyloP 241 on SpliceVarDB intronic SNVs (Evo 2 paper)
- PhyloP 447 on SpliceVarDB intronic SNVs (Evo 2 paper)
Baseline coverage
Reference methods help show what a model adds beyond simple controls. We track a null control and a conventional method for each protocol.
0 of 2 active baseline roles have published Rewire measurements in this release. Measurements on a selected protocol do not establish coverage of an entire suite.
No execution recipe linked to this protocol. Recipe availability does not establish a completed evaluation.
No reviewed evaluations with results linked in this release.
Literature evidence is not a Rewire measurement. Executed but unpublished runs and private review status are not included.
Null control
Proposed control: requires review
Protocol-valid seeded random ranking; no fitting on assay labels
Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.
This is a suggested selection rule, not a validated method or a measured score.
Conventional reference
Proposed control: requires review
Established label-free reference with explicitly permitted sequence/MSA inputs
Protocol-specific applicability, permitted inputs, access, split, evaluator and execution requirements need review before implementation or execution.
This is a suggested selection rule, not a validated method or a measured score.
Protocol coverage CSV (gzip) · Model evaluation matrix (gzip) · Source table (gzip) · Release and checksums (gzip)
Coverage is derived from release 2026-10-22-1b7cf027e4f6. Source citations describe the original records; they do not validate an unreviewed baseline proposal. No results have been generated by this audit.
Run instructions
No runnable recipe has been reviewed for this protocol. Dataset access, model requirements, licences and compute requirements must be checked against its sources before execution.
Strengths, limitations and unresolved questions
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
0 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|
No evidence rows match these filters. Choose another scope or clear the search.
Sources and history
Release 2026-10-22-1b7cf027e4f6 · Record review: source checked
3 source records and release history
- evo2: Journal full-text XML · Original source · Retrieved page snapshot; no immutable publisher revision supplied
- Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026) · Original source · Nature 652 (2026), published 2026-03-04; Supplementary Information file 41586_2026_10176_MOESM1_ESM.pdf (73 pages)
- Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026) · Original source · Nature 652 (2026), published 2026-03-04; Supplementary Data 1 file 41586_2026_10176_MOESM3_ESM.xlsx
Technical metadata and extraction receipts
Stable ID: gfm-guides-20261014-evo2-brixi2026-protocol-splicevardb-intronic-snv
- areas
- dna-genomes
- contexts
- research
- protocol
- Score each variant zero-shot (for Evo 2, the log-likelihood of the variant sequence minus that of the reference over an 8,192-bp genomic window around the variant) and compute AUROC and AUPRC for splice-altering versus other variants in the stratum Data 'SpliceVarDB', Genomic_Feature 'Intronic', Variant_Type 'SNV'.
- version
- As published, Nature 652 (2026), Supplementary Data 1
- source locator
- Supplementary Data 1 rows with Data 'SpliceVarDB', Genomic_Feature 'Intronic', Variant_Type 'SNV', Sub_category ''; SI A.3.12 and A.3.14 (pages 13 and 14); Fig. 3d
- limitations
- Positives: 2567 splice-altering; negatives: 1141 other; total 3708 variants (Supplementary Data 1).; No split: every model scores the same variants zero-shot (SI A.3.12: 'For each benchmark, we score the same variants with all models').; Supervised comparators (AlphaMissense, CADD, SpliceAI, Pangolin) may have been trained on overlapping variants; training overlap is not reported.; No uncertainty is reported.
Related records
- part of: Evo 2 paper zero-shot human variant effect evaluations (Brixi et al. 2026)
- uses data: SpliceVarDB experimentally validated splice variants (Brixi et al. 2026)
- assessment: CADD on SpliceVarDB intronic SNVs (Evo 2 paper)
- assessment: Evo 1 on SpliceVarDB intronic SNVs (Evo 2 paper)
- assessment: Evo 2 40B base on SpliceVarDB intronic SNVs (Evo 2 paper)
- assessment: Evo 2 40B on SpliceVarDB intronic SNVs (Evo 2 paper)
- assessment: Evo 2 7B base on SpliceVarDB intronic SNVs (Evo 2 paper)
- assessment: Evo 2 7B on SpliceVarDB intronic SNVs (Evo 2 paper)
- assessment: GPN-MSA on SpliceVarDB intronic SNVs (Evo 2 paper)
- assessment: NT on SpliceVarDB intronic SNVs (Evo 2 paper)
- assessment: Pangolin on SpliceVarDB intronic SNVs (Evo 2 paper)
- assessment: PhyloP 100 on SpliceVarDB intronic SNVs (Evo 2 paper)
- assessment: PhyloP 241 on SpliceVarDB intronic SNVs (Evo 2 paper)
- assessment: PhyloP 447 on SpliceVarDB intronic SNVs (Evo 2 paper)
- assessment: PhyloP 470 on SpliceVarDB intronic SNVs (Evo 2 paper)
- assessment: RNA-FM on SpliceVarDB intronic SNVs (Evo 2 paper)
- assessment: SpliceAI on SpliceVarDB intronic SNVs (Evo 2 paper)